Effect of pitavastatin on experimental choroidal neovascularization in rats

Experimental Eye Research

Volumn 84, Issue 6, 2007, Pages 1074-1080

  Sagara, Nina ^a   Kawaji, Takahiro ^a   Takano, Akiomi ^a   Inomata, Yasuya ^a   Inatani, Masaru ^a   Fukushima, Mikiko ^a   Tanihara, Hidenobu ^a  

^a KUMAMOTO UNIVERSITY   (Japan)

Author keywords

age related macular degeneration; choroidal neovascularization; HMG CoA reductase inhibitor; pitavastatin

Indexed keywords

FLUORESCEIN ISOTHIOCYANATE DEXTRAN; INTERCELLULAR ADHESION MOLECULE 1; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1; PITAVASTATIN; VASCULOTROPIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; FLUORESCENCE ANGIOGRAPHY; GENE EXPRESSION; HISTOLOGY; HYPOCHOLESTEROLEMIA; MALE; NONHUMAN; OBSERVATIONAL METHOD; PRIORITY JOURNAL; RAT; REAL TIME POLYMERASE CHAIN REACTION; RETINA MACULA AGE RELATED DEGENERATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SUBRETINAL NEOVASCULARIZATION; THICKNESS;

ANIMALS; CHEMOKINE CCL2; CHOROIDAL NEOVASCULARIZATION; DRUG EVALUATION, PRECLINICAL; FLUORESCEIN ANGIOGRAPHY; GENE EXPRESSION REGULATION; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; INTERCELLULAR ADHESION MOLECULE-1; MALE; QUINOLINES; RATS; RATS, INBRED BN; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SEVERITY OF ILLNESS INDEX; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 34248642259     PISSN: 00144835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.exer.2007.02.005     Document Type: Article

References (40)

1. Ambati J., Anand A., Fernandez S., Sakurai E., Lynn B.C., Kuziel W.A., Rollins B.J., and Ambati B.K. An animal model of age-related macular degeneration in senescent Ccl-2- or Ccr-2-deficient mice. Nat. Med. 9 (2003) 1390-1397
2. Bellosta S., Ferri N., Bernini F., Paoletti R., and Corsini A. Non-lipid-related effects of statins. Ann. Med. 32 (2000) 164-176
3. Delcourt C., Michel F., Colvez A., Lacroux A., Delage M., and Vernet M.H. Associations of cardiovascular disease and its risk factors with age-related macular degeneration: the POLA study. Ophthalmic. Epidemiol. 8 (2001) 237-249
4. Edelman J.L., and Castro M.R. Quantitative image analysis of laser-induced choroidal neovascularization in rat. Exp. Eye Res. 71 (2000) 523-533
5. Fine S.L., Berger J.W., Maguire M.G., and Ho A.C. Age-related macular degeneration. N. Engl. J. Med. 342 (2000) 483-492
6. Frick M., Dulak J., Cisowski J., Jozkowicz A., Zwick R., Alber H., Dichtl W., Schwarzacher S.P., Pachinger O., and Weidinger F. Statins differentially regulate vascular endothelial growth factor synthesis in endothelial and vascular smooth muscle cells. Atherosclerosis 170 (2003) 229-236
7. Grossniklaus H.E., Ling J.X., Wallace T.M., Dithmar S., Lawson D.H., Cohen C., Elner V.M., Elner S.G., and Sternberg Jr. P. Macrophage and retinal pigment epithelium expression of angiogenic cytokines in choroidal neovascularization. Mol. Vis. 8 (2002) 119-126
8. Hall N.F., Gale C.R., Syddall H., Phillips D.I., and Martyn C.N. Risk of macular degeneration in users of statins: cross sectional study. BMJ 323 (2001) 375-376
9. Hess D.C., and Fagan S.C. Pharmacology and clinical experience with simvastatin. Expert Opin. Pharmacother. 2 (2001) 153-163
10. Honjo M., Tanihara H., Nishijima K., Kiryu J., Honda Y., Yue B.Y., and Sawamura T. Statin inhibits leukocyte-endothelial interaction and prevents neuronal death induced by ischemia-reperfusion injury in the rat retina. Arch. Ophthalmol. 120 (2002) 1707-1713
11. Jialal I., Stein D., Balis D., Grundy S.M., Adams-Huet B., and Devaraj S. Effect of hydroxymethyl glutaryl coenzyme a reductase inhibitor therapy on high sensitive C-reactive protein levels. Circulation 103 (2001) 1933-1935
12. Klaver C.C., Assink J.J., van Leeuwen R., Wolfs R.C., Vingerling J.R., Stijnen T., Hofman A., and de Jong P.T. Incidence and progression rates of age-related maculopathy: the Rotterdam Study. Invest. Ophthalmol. Vis. Sci. 42 (2001) 2237-2241
13. Klein R., Klein B.E., Tomany S.C., Danforth L.G., and Cruickshanks K.J. Relation of statin use to the 5-year incidence and progression of age-related maculopathy. Arch. Ophthalmol. 121 (2003) 1151-1155
14. Kvanta A., Algvere P.V., Berglin L., and Seregard S. Subfoveal fibrovascular membranes in age-related macular degeneration express vascular endothelial growth factor. Invest. Ophthalmol. Vis. Sci. 37 (1996) 1929-1934
15. Kwak B., Mulhaupt F., Veillard N., Pelli G., and Mach F. The HMG-CoA reductase inhibitor simvastatin inhibits IFN-gamma induced MHC class II expression in human vascular endothelial cells. Swiss. Med. Wkly. 131 (2001) 41-46
16. Lopez P.F., Sippy B.D., Lambert H.M., Thach A.B., and Hinton D.R. Transdifferentiated retinal pigment epithelial cells are immunoreactive for vascular endothelial growth factor in surgically excised age-related macular degeneration-related choroidal neovascular membranes. Invest. Ophthalmol. Vis. Sci. 37 (1996) 855-868
17. Mahley R.W., Huang Y., and Rall Jr. S.C. Pathogenesis of type III hyperlipoproteinemia (dysbetalipoproteinemia). Questions, quandaries, and paradoxes. J. Lipid Res. 40 (1999) 1933-1949
18. McCarty C.A., Mukesh B.N., Fu C.L., Mitchell P., Wang J.J., and Taylor H.R. Risk factors for age-related maculopathy: the Visual Impairment Project. Arch. Ophthalmol. 119 (2001) 1455-1462
19. McGwin Jr. G., Modjarrad K., Hall T.A., Xie A., and Owsley C. 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitors and the presence of age-related macular degeneration in the Cardiovascular Health Study. Arch. Ophthalmol. 124 (2006) 33-37
20. McGwin Jr. G., Owsley C., Curcio C.A., and Crain R.J. The association between statin use and age related maculopathy. Br. J. Ophthalmol. 87 (2003) 1121-1125
21. Mesri M., Liversidge J., and Forrester J.V. ICAM-1/LFA-1 interactions in T-lymphocyte activation and adhesion to cells of the blood-retina barrier in the rat. Immunology 83 (1994) 52-57
22. Mitchell P., Smith W., Attebo K., and Wang J.J. Prevalence of age-related maculopathy in Australia. The Blue Mountains Eye Study. Ophthalmology 102 (1995) 1450-1460
23. Mitchell P., Wang J.J., Smith W., and Leeder S.R. Smoking and the 5-year incidence of age-related maculopathy: the Blue Mountains Eye Study. Arch. Ophthalmol. 120 (2002) 1357-1363
24. Plenge J.K., Hernandez T.L., Weil K.M., Poirier P., Grunwald G.K., Marcovina S.M., and Eckel R.H. Simvastatin lowers C-reactive protein within 14 days: an effect independent of low-density lipoprotein cholesterol reduction. Circulation 106 (2002) 1447-1452
25. Pruefer D., Scalia R., and Lefer A.M. Simvastatin inhibits leukocyte-endothelial cell interactions and protects against inflammatory processes in normocholesterolemic rats. Arterioscler. Thromb. Vasc. Biol. 19 (1999) 2894-2900
26. Romano M., Diomede L., Sironi M., Massimiliano L., Sottocorno M., Polentarutti N., Guglielmotti A., Albani D., Bruno A., Fruscella P., Salmona M., Vecchi A., Pinza M., and Mantovani A. Inhibition of monocyte chemotactic protein-1 synthesis by statins. Lab. Invest. 80 (2000) 1095-1100
27. Sakurai E., Taguchi H., Anand A., Ambati B.K., Gragoudas E.S., Miller J.W., Adamis A.P., and Ambati J. Targeted disruption of the CD18 or ICAM-1 gene inhibits choroidal neovascularization. Invest. Ophthalmol. Vis. Sci. 44 (2003) 2743-2749
28. Semkova I., Peters S., Welsandt G., Janicki H., Jordan J., and Schraermeyer U. Investigation of laser-induced choroidal neovascularization in the rat. Invest. Ophthalmol. Vis. Sci. 44 (2003) 5349-5354
29. Shen W.Y., Yu M.J., Barry C.J., Constable I.J., and Rakoczy P.E. Expression of cell adhesion molecules and vascular endothelial growth factor in experimental choroidal neovascularisation in the rat. Br. J. Ophthalmol. 82 (1998) 1063-1071
30. Takehana Y., Kurokawa T., Kitamura T., Tsukahara Y., Akahane S., Kitazawa M., and Yoshimura N. Suppression of laser-induced choroidal neovascularization by oral tranilast in the rat. Invest. Ophthalmol. Vis. Sci. 40 (1999) 459-466
31. Takemoto M., and Liao J.K. Pleiotropic effects of 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitors. Arterioscler. Thromb. Vasc. Biol. 21 (2001) 1712-1719
32. Tanemura M., Miyamoto N., Mandai M., Kamizuru H., Ooto S., Yasukawa T., Takahashi M., and Honda Y. The role of estrogen and estrogen receptorbeta in choroidal neovascularization. Mol. Vis. 10 (2004) 923-932
33. Urbich C., Dernbach E., Zeiher A.M., and Dimmeler S. Double-edged role of statins in angiogenesis signaling. Circ. Res. 90 (2002) 737-744
34. Vaughan C.J., Gotto Jr. A.M., and Basson C.T. The evolving role of statins in the management of atherosclerosis. J. Am. Coll. Cardiol. 35 (2000) 1-10
35. Wassmann S., Faul A., Hennen B., Scheller B., Bohm M., and Nickenig G. Rapid effect of 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibition on coronary endothelial function. Circ. Res. 93 (2003) e98-e103
36. Weis M., Heeschen C., Glassford A.J., and Cooke J.P. Statins have biphasic effects on angiogenesis. Circulation 105 (2002) 739-745
37. Wilson H.L., Schwartz D.M., Bhatt H.R., McCulloch C.E., and Duncan J.L. Statin and aspirin therapy are associated with decreased rates of choroidal neovascularization among patients with age-related macular degeneration. Am. J. Ophthalmol. 137 (2004) 615-624
38. Yi X., Ogata N., Komada M., Yamamoto C., Takahashi K., Omori K., and Uyama M. Vascular endothelial growth factor expression in choroidal neovascularization in rats. Graefes Arch. Clin. Exp. Ophthalmol. 235 (1997) 313-319
39. Zambarakji H.J., Nakazawa T., Connolly E., Lane A.M., Mallemadugula S., Kaplan M., Michaud N., Hafezi-Moghadam A., Gragoudas E.S., and Miller J.W. Dose-dependent effect of pitavastatin on VEGF and angiogenesis in a mouse model of choroidal neovascularization. Invest. Ophthalmol. Vis. Sci. 47 (2006) 2623-2631
40. Zarbin M.A. Current concepts in the pathogenesis of age-related macular degeneration. Arch. Ophthalmol. 122 (2004) 598-614